×
About 452 results

ALLMedicine™ Intermediate Uveitis Center

Research & Reviews  221 results

Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate...
https://doi.org/10.1016/j.ophtha.2020.10.036
Ophthalmology Suhler EB, Jaffe GJ et. al.

Nov 6th, 2020 - To evaluate long-term efficacy and safety of extended treatment with adalimumab in patients with noninfectious intermediate, posterior, or panuveitis. Open-label, multicenter, phase 3 extension study (VISUAL III). Adults who had completed a random...

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
https://doi.org/10.1016/j.ophtha.2020.06.052
Ophthalmology Agrawal R, Testi I et. al.

Jun 30th, 2020 - The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to de...

Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterio...
https://doi.org/10.1016/j.ophtha.2020.03.033
Ophthalmology Merrill PT, Clark WL et. al.

Jun 22nd, 2020 - To evaluate the efficacy and safety of intravitreal sirolimus in the management of noninfectious uveitis of the posterior segment (NIU-PS). Combined analysis of 2 phase 3, randomized, double-masked, multinational, 6-month studies. Adults with acti...

Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multipl...
https://doi.org/10.1016/j.msard.2020.102152
Multiple Sclerosis and Related Disorders; Lopalco G, Schiraldi S et. al.

May 14th, 2020 - Multiple sclerosis (MS) is a chronic demyelinating disorder of central nervous system (CNS) leading to neurological disability. A wide variety of ophthalmic and neuro-ophthalmic manifestations have been associated with MS. Although this link is we...

INTERMEDIATE UVEITIS WITH RETINAL DETACHMENT IN A PATIENT WITH POMPE DISEASE.
https://doi.org/10.1097/ICB.0000000000000971
Retinal Cases & Brief Reports; Thomas AS, Grewal DS et. al.

Jan 27th, 2020 - To describe the ocular findings in a patient with glycogen storage disease II (Pompe disease). Case report. A 14-year-old boy with Pompe disease was referred for evaluation of a retinal detachment in the left eye. Indirect ophthalmoscopy revealed ...

see more →

Clinicaltrials.gov  227 results

Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate...
https://doi.org/10.1016/j.ophtha.2020.10.036
Ophthalmology Suhler EB, Jaffe GJ et. al.

Nov 6th, 2020 - To evaluate long-term efficacy and safety of extended treatment with adalimumab in patients with noninfectious intermediate, posterior, or panuveitis. Open-label, multicenter, phase 3 extension study (VISUAL III). Adults who had completed a random...

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
https://doi.org/10.1016/j.ophtha.2020.06.052
Ophthalmology Agrawal R, Testi I et. al.

Jun 30th, 2020 - The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to de...

Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterio...
https://doi.org/10.1016/j.ophtha.2020.03.033
Ophthalmology Merrill PT, Clark WL et. al.

Jun 22nd, 2020 - To evaluate the efficacy and safety of intravitreal sirolimus in the management of noninfectious uveitis of the posterior segment (NIU-PS). Combined analysis of 2 phase 3, randomized, double-masked, multinational, 6-month studies. Adults with acti...

Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multipl...
https://doi.org/10.1016/j.msard.2020.102152
Multiple Sclerosis and Related Disorders; Lopalco G, Schiraldi S et. al.

May 14th, 2020 - Multiple sclerosis (MS) is a chronic demyelinating disorder of central nervous system (CNS) leading to neurological disability. A wide variety of ophthalmic and neuro-ophthalmic manifestations have been associated with MS. Although this link is we...

INTERMEDIATE UVEITIS WITH RETINAL DETACHMENT IN A PATIENT WITH POMPE DISEASE.
https://doi.org/10.1097/ICB.0000000000000971
Retinal Cases & Brief Reports; Thomas AS, Grewal DS et. al.

Jan 27th, 2020 - To describe the ocular findings in a patient with glycogen storage disease II (Pompe disease). Case report. A 14-year-old boy with Pompe disease was referred for evaluation of a retinal detachment in the left eye. Indirect ophthalmoscopy revealed ...

see more →

News  4 results

FDA Clears Adalimumab (Humira) for Uveitis
https://www.staging.medscape.com/viewarticle/865654

Jun 30th, 2016 - The US Food and Drug Administration (FDA) has approved adalimumab (Humira, AbbVie) for use in patients with noninfectious intermediate and posterior uveitis and panuveitis, the company announced. Adalimumab is the first and only FDA-approved nonco...

FDA Clears Adalimumab (Humira) for Uveitis
https://www.medscape.com/viewarticle/865654

Jun 30th, 2016 - The US Food and Drug Administration (FDA) has approved adalimumab (Humira, AbbVie) for use in patients with noninfectious intermediate and posterior uveitis and panuveitis, the company announced. Adalimumab is the first and only FDA-approved nonco...

FDA Grants Orphan Drug Status to Gevokizumab
https://www.medscape.com/viewarticle/769952

Aug 28th, 2012 - August 29, 2012 — The US Food and Drug Administration (FDA) has granted orphan drug status to gevokizumab (Xoma 052, Xoma Corp), a monoclonal antibody that binds strongly to interleukin 1β (IL-1β), for the treatment of noninfectious intermediate u...

Systemic diseases associated with intermediate uveitis
https://www.mdedge.com/ccjm/article/92786/systemic-diseases-associated-intermediate-uveitis

Abstract BACKGROUND Intermediate uveitis is characterized by vitreal inflammation with associated inflammation of the vitreous base and peripheral anterior retina and choroid. It may be found as an isolated and idiopathic condition or in associati.

see more →